Prognostic variables in invasive breast cancer: Contribution of comedo versus noncomedo in situ component
- 35 Downloads
Background: Many invasive breast cancers are accompanied by a variety of noninvasive components. Histological distinctions have been made between these components, but to understand their importance, it is essential to examine their molecular biology.
Methods: Proliferative indices, oncoproteins, and steroid receptor expression were compared for invasive breast cancers containing comedo-type ductal carcinoma in situ (n=35), noncomedo-type ductal carcinoma in situ (n=34), and pure invasive cancers (n=49). Ploidy, S-phase fraction, Ki-67 staining, estrogen receptor (ER), progesterone receptor (PR), and the expression of HER-2/neu and epidermal growth factor receptor (EGFR) were evaluated in these tumors.
Results: The comedo-invasive subgroup differed significantly from the noncomedoinvasive subgroup, demonstrating significantly higher mean ploidy (1.6 vs. 1.3;p=0.0156), S-phase fraction (7.9% vs. 4.3%;p=0.0066), Ki-67 staining (20.3% vs. 12.0%;p=0.0058), and HER-2/neu values (2,247 fm/mg vs. 1,014 fm/mg;p=0.0412) and lower ER (76 fm/mg vs. 339 fm/mg;p=0.006) and PR values (99 fm/mg vs. 265 fm/mg;p=0.0608). A higher percentage of comedo-invasive carcinomas demonstrated aneuploidy (71%;p=0.0158), elevated levels of S-phase fraction (75%;p=0.0016) and Ki-67 staining (55%;p=0.0512), overexpression of HER-2/neu oncogene (47%;p=0.0011), and were ER negative (35%;p=0.0148), PR negative (47%;p=0.0073) when compared to noncomedo-invasive carcinomas. Comedo-invasive and noncomedo-invasive tumors were comparable for nodal status and tumor size, but differences were noted for tumor differentiation and percentage of tumors that were >1 cm. Comedo-invasive tumors were predominantly poorly differentiated (60 vs. 32%) and were >1 cm (94 vs. 77%,p<0.05).
Results: Comedo-invasive cancers were comparable to pure invasive cancers for ploidy, S-phase fraction, Ki-67 staining, and ER, PR, and EGFR expression. However, comedoinvasive carcinomas had greater HER-2/neu overexpression when compared to pure invasive tumors (47 vs. 19%;p=0.0359).
Conclusions: These results are consistent with the hypothesis that comedo carcinoma is a more aggressive type of ductal carcinoma in situ and may have independent prognostic value when seen in association with infiltrating ductal carcinoma. In invasive tumors, comedo carcinomas are associated with poor prognostic factors, including higher ploidy, S-phase fractions, Ki-67 staining, negative ER and PR status, poorer differentiation, larger tumors, and presence of HER-2/neu oncogene overexpression.
Key WordsBreast cancers Oncogenes Proliferative indices
Unable to display preview. Download preview PDF.
- 9.Aasmudstad TA, Haugen OA. DNA ploidy in intraductal breast carcinomas.Eur J Cancer 1990;26:956–9.Google Scholar
- 10.Ahmed S, Tartter PI, Brower ST, Weiss SE, Brusco C, Bossolt K, Brower ST, et al. Comparison of invasive cancers with and without extensive intraductal component.Breast Dis (in press).Google Scholar
- 12.Thorpe SM. Estrogen and progesterone receptor determinations in breast cancer.Acta Oncol 1987;27:1–19.Google Scholar
- 14.Slamom D et al. Studies of the HER/2-neu protooncogene in human breast and ovarian cancer.Science 1989;244:707–12.Google Scholar
- 19.Dressler LG, Clark GM, Owens MA, McGuire WL. DNA flow cytometry and its relationship to clinical variables in breast cancer. In: Brescioni F, ed.Progress in cancer research and therapy, vol. 35: hormones and cancer. New York: Raven Press, 1988:394–9.Google Scholar
- 22.Lippman ME. The role of theerb B2 receptor and its ligands in human breast cancer. In:Proceedings of Molecular Biology in Clinical Oncology: a Workship. Aspen, CO: American Association of Cancer Research, 1993:20.Google Scholar